IEX
IDEX Corporation NYSE$214.33
Mkt Cap $15.9B
52w Low $157.25
85.7% of range
52w High $223.85
50d MA $199.51
200d MA $181.29
P/E (TTM)
33.5x
EV/EBITDA
16.2x
P/B
4.0x
Debt/Equity
0.5x
ROE
12.0%
P/FCF
21.7x
RSI (14)
—
ATR (14)
—
Beta
0.98
50d MA
$199.51
200d MA
$181.29
Avg Volume
874.2K
About
IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, small volume provers, flow meters, injectors, and other fluid-hand…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | TNS | 1.78 | 2.00 | +12.4% | 217.34 | +0.9% | +0.2% | -1.1% | -1.4% | -0.6% | — | — |
| Feb 4, 2026 | TNS | 2.04 | 2.10 | +2.9% | 212.25 | -0.0% | +0.3% | -0.4% | -0.7% | +1.1% | -0.4% | — |
| Oct 29, 2025 | TNS | 1.93 | 2.03 | +5.2% | 173.40 | -0.1% | -1.8% | -1.1% | -3.0% | -3.2% | -3.0% | — |
| Jul 30, 2025 | TNS | 2.00 | 2.07 | +3.5% | 164.28 | -1.1% | -0.5% | -3.1% | -3.7% | -1.5% | -2.8% | — |
| May 1, 2025 | TNS | 1.64 | 1.75 | +6.7% | 175.25 | +2.3% | +3.5% | +3.7% | +2.4% | +2.8% | +5.4% | — |
| Feb 4, 2025 | TNS | 2.03 | 2.04 | +0.5% | 218.65 | -4.8% | -9.6% | -8.8% | -10.4% | -10.2% | -10.9% | — |
| Oct 29, 2024 | TNS | 1.89 | 1.90 | +0.5% | 203.88 | +2.8% | +7.2% | +5.3% | +6.0% | +7.4% | +10.2% | — |
| Jul 31, 2024 | TNS | 2.04 | 2.06 | +1.0% | 208.48 | -1.4% | -5.8% | -6.9% | -7.8% | -7.8% | -8.6% | — |
| Apr 23, 2024 | TNS | 1.76 | 1.88 | +6.8% | 232.27 | -0.5% | -3.3% | -3.9% | -5.0% | -3.6% | -5.1% | — |
| Feb 6, 2024 | TNS | 1.78 | 1.83 | +2.8% | 218.89 | +1.7% | +1.6% | +3.2% | +4.3% | +3.7% | +2.5% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 | TD Cowen | Maintains | Buy → Buy | — | $217.34 | $219.19 | +0.9% | +0.2% | -1.1% | — | — | — |
| Apr 30 | Citigroup | Maintains | Buy → Buy | — | $217.34 | $219.19 | +0.9% | +0.2% | -1.1% | — | — | — |
| Apr 30 | RBC Capital | Maintains | Outperform → Outperform | — | $217.34 | $219.19 | +0.9% | +0.2% | -1.1% | — | — | — |
| Apr 14 | Stifel | Maintains | Buy → Buy | — | $205.12 | $204.61 | -0.2% | -0.1% | -2.7% | -2.1% | +0.4% | +0.6% |
| Mar 27 | BMO Capital | Maintains | Market Perform → Market Perform | — | $189.73 | $189.42 | -0.2% | -1.7% | -3.3% | -0.1% | +1.2% | +0.4% |
| Feb 6 | Argus | Upgrade | Hold → Buy | — | $212.94 | $215.20 | +1.1% | -0.7% | -1.0% | +0.8% | -0.7% | -3.7% |
| Feb 5 | TD Cowen | Maintains | Buy → Buy | — | $212.25 | $212.23 | -0.0% | +0.3% | -0.4% | -0.7% | +1.1% | -0.4% |
| Feb 5 | Citigroup | Maintains | Buy → Buy | — | $212.25 | $212.23 | -0.0% | +0.3% | -0.4% | -0.7% | +1.1% | -0.4% |
| Feb 5 | RBC Capital | Maintains | Outperform → Outperform | — | $212.25 | $212.23 | -0.0% | +0.3% | -0.4% | -0.7% | +1.1% | -0.4% |
| Feb 5 | DA Davidson | Maintains | Neutral → Neutral | — | $212.25 | $212.23 | -0.0% | +0.3% | -0.4% | -0.7% | +1.1% | -0.4% |
Recent Filings
8-K
IDEX Corporation -- 8-K Filing
IDEX Corporation exceeded first-quarter expectations driven by strong performance in Health Science Technologies growth platforms, signaling healthy demand momentum across key business divisions.
Apr 29
8-K
IDEX Corporation -- 8-K Filing
I cannot provide a meaningful investment analysis from this filing summary, as it contains only technical XBRL metadata and reference information rather than substantive corporate action or financial news.
Feb 9
8-K
IDEX Corporation -- 8-K Filing
IDEX Corporation demonstrated strong platform growth execution in 2025, with CEO Eric Ashleman highlighting positive results from the company's strategic initiatives across global operations.
Feb 4
Data updated apr 25, 2026 3:02pm
· Source: massive.com